Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

Rhea-AI Summary

Asensus Surgical, Inc. (NYSE American: ASXC) announced that CFO Shameze Rampertab will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference in Miami on December 8, 2022. The company will present a panel discussion on early commercial MedTech technologies at 11:00 AM ET, followed by a Key Opinion Leader Luncheon at 12:15 PM ET, featuring Dr. Steven McCarus. Asensus is focused on enhancing surgical outcomes through Performance-Guided Surgery™ and the Senhance® Surgical System, which is currently available in multiple regions.

RESEARCH TRIANGLE PARK, N.C., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference in Miami, Florida. The Company’s panel presentation, Launching on Society: Early Commercial MedTech Names with New Technologies in Large Patient Populations, will take place on Thursday, December 8, 2022 at 11:00 AM Eastern Time. A Key Opinion Leader Luncheon presentation, A Discussion on Robotic Devices in Surgery, will also be held on Thursday, December 8, 2022 at 12:15 PM Eastern Time, featuring Dr. Steven McCarus,Chief of Gynecology Surgery at AdventHealth Winter Park, Florida.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance® Surgical System powered by the Intelligent Surgical Unit™ (ISU™) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

Follow Asensus

• Email Alerts: https://ir.asensus.com/email-alerts
• LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc
• Twitter: https://twitter.com/AsensusSurgical
• YouTube: https://www.youtube.com/c/transenterix
• Vimeo: https://vimeo.com/asxc
• TikTok: https://www.tiktok.com/@asensus_surgical

INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
or
MEDIA CONTACT:
Isabella Rodriguez, 708-833-1572
CG Life
irodriguez@cglife.com

FAQ

When is the Cantor Medical & Aesthetic Dermatology Conference featuring ASXC?

The Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference featuring Asensus Surgical will take place on December 8, 2022.

Who is presenting for Asensus Surgical at the conference?

Shameze Rampertab, CFO of Asensus Surgical, will present at the conference.

What is the focus of Asensus Surgical's presentation at the conference?

Asensus Surgical's presentation will focus on early commercial MedTech technologies and robotic devices in surgery.

What time is Asensus Surgical's panel discussion at the conference?

Asensus Surgical's panel discussion is scheduled for 11:00 AM Eastern Time on December 8, 2022.

Who will participate in the Key Opinion Leader Luncheon presentation?

Dr. Steven McCarus, Chief of Gynecology Surgery at AdventHealth Winter Park, will participate in the Key Opinion Leader Luncheon presentation.